Open Access

Expression profiling of circulating non-red blood cells in embryonic blood

  • Brendan AS McIntyre1,
  • Cantas Alev1, 2,
  • Hiroshi Tarui3,
  • Lars M Jakt4 and
  • Guojun Sheng1Email author
BMC Developmental Biology20088:21

https://doi.org/10.1186/1471-213X-8-21

Received: 03 September 2007

Accepted: 27 February 2008

Published: 27 February 2008

Abstract

Background

In addition to erythrocytes, embryonic blood contains other differentiated cell lineages and potential progenitor or stem cells homed to changing niches as the embryo develops. Using chicken as a model system, we have isolated an enriched pool of circulating non red blood cells (nRBCs) from E4 and E6 embryos; a transition period when definitive hematopoietic lineages are being specified in the peri-aortic region.

Results

Transcriptome analysis of both nRBC and RBC enriched populations was performed using chicken Affymetrix gene expression arrays. Comparison of transcript profiles of these two populations, with verification by RT-PCR, reveals in nRBCs an expression signature indicative of hematopoietic stem cells (HSCs) and progenitor cells of myeloid and lymphoid lineages, as well as a number of previously undescribed genes possibly involved in progenitor and stem cell maintenance.

Conclusion

This data indicates that early circulating embryonic blood contains a full array of hematopoietic progenitors and stem cells. Future studies on their heterogeneity and differentiation potentials may provide a useful alternative to ES cells and perinatal blood.

Background

The isolation and gene expression profiling of embryonic circulating nRBCs would be of great interest to developmental biologists and clinicians alike [1], yet due to limited sample size available from traditionally used model organisms, harvesting a sufficiently large pool of embryonic nRBCs for transcriptome-wide analysis has been difficult. Alternative approaches using perinatal blood have already yielded significant insights [2]. The chick embryo is both large in size and contains a circulatory network of a complexity equal to that of mammals. Herein, we describe the isolation and gene expression profiling of circulating cells during the transition phase of hematopoiesis from primitive or yolk sac associated, to definitive hematopoiesis, at embryonic days 4 and 6. It is during this time that hematopoiesis occurs transiently in the peri-aortic region in the chick embryo (referred to in mammals as the aorta-gonad-mesonephros or AGM), before transitioning to the bone marrow [3, 4].

Results and Discussion

Chick blood was isolated from embryos at E4 and E6, using micro-capillaries inserted directly into the heart. Density gradient centrifugation was then employed to isolate the heavier RBCs from a lighter nRBC population from total embryonic blood. Cells within the two populations were analyzed directly by FACS, and by the classical hematological stains Giemsa, benzidine, and Periodic-acid Schiff (PAS). Using these techniques, we were able to confirm that two distinct, viable populations; one highly enriched in RBCs, and another population highly depleted of RBCs (nRBCs) had been isolated (Fig. 1).
Figure 1

Characterization of RBC and nRBC cellular fractions. (A) Appearance of cell populations following density gradient centrifugation, along with control density marker beads. (B) FACSAria (BD Biosciences) profile of RBC and nRBCs after propidium iodide labeling of dead cells. The number of small (FSC), agranular (SSC) cells is greater in the nRBC fraction; >90% of cells from both populations are viable based on propidium iodide exclusion and Trypan blue exclusion (not shown). (C) nRBCs have a large nuclear volume, and smaller size (Giemsa), are benzidine negative and PAS positive. Bar = 20 μm.

Further characterization of these populations by RT-PCR demonstrated that nRBCs had high expression levels of the hematopoietic stem cell antigen CD34, whereas the RBC population lacked expression of this gene (Fig. 2B,C). After these preliminary findings had given validity to our technique, gene expression profiling was performed using Affymetrix Gene Expression Arrays. For RNA isolation, handling time was kept to a minimum and cell collection to lysis for RNA extraction was performed in less than one hour. Consequently, cells were not subjected to long incubation periods on ice, or in serum containing medium, which can alter gene expression, as is the case for other commonly used in techniques such as FACS sorting. RNA from both E4 and E6 RBC and nRBC samples were analyzed by duplicate Affymetrix gene chips, from separate, pooled biological samples (30–100 embryos/array). Comparisons between RBC and nRBC populations were made, and the expression levels of candidate genes were confirmed by PCR (Fig. 2A–C). The resulting array data has been deposited into NCBI Gene Expression Omnibus (GEO) under the accession number GSE9884. We considered genes to be significantly enriched in the nRBC population by the following two criteria: 1) that they are expressed at higher levels in the nRBC than the RBC population by the SAM algorithm; 2) that they are not expressed at high levels in the heart (Fig. 3).
Figure 2

Array analysis and RT-PCR verification. (A) Heat map generated by TM4 SAM analysis with genes verified by PCR highlighted. (B) Semi-quantitative PCR analysis of candidate genes from array data and control GAPDH and 18S, and embryonic hemoglobin transcripts (pan-globin) in cDNAs from both E4 and E6 RBC and nRBC fractions. (C) QPCR data. All genes tested had significantly higher expression in nRBCs by Student's T-test (except for CD51). Hemoglobins are the only genes with significantly higher expression in RBCs. E4 data: left-hand bars, E6 data: right-hand bars.

Figure 3

Representative array expression profiles generated by eXintegrator analysis. Example candidate genes kept from TM4 analysis (left) display an observable gradient of low expression in RBC samples and high expression in nRBC samples, and low-to-moderate expression in heart. Example candidate genes discarded from TM4 analysis (right) following examination by eXintegrator display high expression in negative control sample (heart).

Hematopoietic Stem Cell (HSC) Associated Genes are Upregulated in nRBCs

Many genes known to be associated with HSCs were found to be preferentially expressed in nRBCs, such as the HSC membrane receptor glycoprotein (GP) CD45 (Tables 1 and 2) [5]. Moreover, transcription factors Ets-1 [6], HEX [7], KLF2 [8] and PU.1 [9], known to be essential for primitive and definitive hematopoiesis, were detected specifically in the nRBC population; as were the signaling molecules BLNK [6], FYN [10], RGS18 [11], Rac2 [12], LYN and SYK [13], VAV3 [14] and the ion channel Slo1 [15]. Additionally, the expression of many integrins, which are known to play an important role in the adhesion and homing of HSCs, were detected in nRBCs. A significant overlapping integrin repertoire was observed between nRBCs and a previous study on adipose derived stromal CD31+ HSCs and includes: CD18 (ITGB2), CD49B (ITGA2), CD49F (ITGA6), CD51 (ITGAV), CD61 (ITGB3/GPIIIa), and the non-integrin cell adhesion molecule CD166 (ALCAM) [16]. In addition to integrins, previous work has established an important role for GPs (e.g. CD34, CD45, CD61) in the adhesion and possibly homing of HSCs, and has demonstrated the expression of the GP receptor CD62L, and the GP Cystatin-7 on HSCs [17, 18]. Finally, cell-cell communication required during later differentiation of HSCs in the stroma is known to be mediated by the gap junctional protein connexin 43 (Cx43), another gene detected in the nRBC population [19].
Table 1

Genes significantly upregulated in nRBCs. Listed genes are ranked according to expression level in nRBCs shown as Log2 expression values. Genes highlighted in bold were verified by PCR.

Probe Set ID

Gene Name

nRBC

RBC

Gga.1039.1.S1_at

CD61, Integrin Beta 3 (Platelet Glycoprotein IIIa)

7.53

0.81

Gga.4472.3.S1_x_at

Thymosin Beta 4 TOLL-Like Receptor 7 (TLR7)

7.5

2.35

Gga.9122.1.S1_at

ETS-1 (p54)

7.31

-0.07

Gga.15362.1.S1_at

RGS18 Regulator of G-protein Signalling 18

7.11

-3.73

Gga.1187.2.S1_s_at

PINCH-1 hypothetical

7.07

4.02

Gga.5362.1.S1_a_at

Elfin, PDZ and LIM Domain Protein 1 (PDLIM-1)

6.81

-0.18

Gga.10042.1.S1_a_at

CD200 Receptor 1 (CD200R)

6.78

-1.78

Gga.6387.1.S1_at

p21 Rac2

6.74

-1.68

Gga.2876.1.S2_a_at

VAV3

6.65

-1.71

Gga.19950.1.S1_s_at

Coagulation Factor XIII, A1 Polypeptide

6.49

-2.26

Gga.3316.1.S1_s_at

HEX probox protein

6.44

1.91

Gga.12960.1.S1_at

Phospholipase C Gamma 2 (PLCG2)

6.29

-1.81

Gga.4451.1.S1_at

Gelsolin

6.14

0.08

Gga.9413.1.A1_at

Prostaglandin-Endoperoxide Synthase 1 (COX-1)

6.06

2.28

Gga.6665.1.A1_at

Peptide Methionine Sulfoxide Reductase (MSRA)

5.98

-1.16

Gga.514.1.S1_at

Coagulation Factor X Precursor Virus Activating Protease

5.79

-1.51

Gga.7018.1.S1_s_at

Fgd3, FYVE, RhoGEF and PH domain containing 3

5.79

0.51

GgaAffx.13009.1.S1_at

Tumor Necrosis Factor Alpha Induced Protein 8 (TNFAIP-8)

5.52

1.71

Gga.4772.1.S1_at

Connexin 43 (Cx43)

5.46

-3.4

Gga.11854.1.S1_at

Tetraspanin 6 (TSPAN6)

5.44

0.48

Gga.4350.1.S2_at

FYN Oncogene Related to SRC, FGR, YES

5.32

-0.29

Gga.1193.1.S2_at

CD45, Protein Tyrosine Phosphatase Receptor Type C

5.24

-1.89

Gga.3828.1.S1_at

ZOV3, Embigin Homolog

5.24

0.61

Gga.16474.1.S1_at

Pleiotrophin (PTN) Osteoblast-Specific Factor 1 (OSF-1)

5.16

-3.79

GgaAffx.21842.1.S1_s_at

Beta Defensin 7 (Gal 7)

5.13

0.18

Gga.11496.1.S1_at

CD62L, L-Selectin

5.09

-1.48

Gga.4225.1.S1_at

Leukocyte Cell-derived Chemotaxin 2 (LECT2)

4.89

0.24

Gga.10034.1.S1_at

Similar to Plasminogen Activator Inhibitor (PAI)

4.85

-3.93

Gga.2734.1.S2_at

CD166, Activated Leukocyte Cell Adhesion Molecule (ALCAM)

4.67

-2.35

Gga.13583.1.S1_at

CD36, Thrombospondin Receptor (Platelet Glycoprotein IV)

4.66

-2.74

Gga.2967.1.S2_at

CD49F, VLA6, Integrin Alpha 6

4.47

-0.16

Gga.19342.1.S1_at

Calcium-Activated Potassium Channel Subunit Alpha, Slowpoke (Slo1)

4.45

-3.99

Gga.5758.1.S1_s_at

LYN, Yamaguchi Sarcoma Viral Related Oncogene Homolog (vYES-1)

4.45

-1.42

GgaAffx.12646.1.S1_at

Spleen Tyrosine Kinase (SYK)

4.42

-2.6

Gga.3899.3.S1_a_at

Platelet-Derived Growth Factor Alpha (PDGF-A)

4.38

-2.38

Gga.4832.1.S1_at

Interferon Inducible Transmembrane Protein 3 (IITMP3, Fragilis)

4.25

-0.06

Gga.11657.1.S1_at

Thrombin Receptor, Coagulation Factor II Receptor

4.02

-1.14

Gga.11741.1.S1_a_at

Tissue Factor Pathway Inhibitor (Lipoprotein-Associated Coagulation Inhibitor)

3.98

-2.99

Gga.15893.1.S1_at

CD49B, Integrin Alpha 2 (Platelet Glycoprotein IIb)

3.94

-2.95

GgaAffx.22186.2.S1_s_at

Interleukin-1 Receptor Accessory Protein Precursor (IL1RAP)

3.88

-1.26

GgaAffx.13138.1.S1_at

Tumor Necrosis Factor (ligand) Superfamily Member 13b (TNFSF-13b)

3.75

-1.88

GgaAffx.13210.1.S1_at

SRC Like Adaptor (SLAP)

3.62

-4.21

Gga.690.1.S1_at

LY64, MD-1

3.51

-0.47

Gga.3738.1.S1_at

B-cell Linker (BLNK)

3.46

-1.18

Gga.4943.1.S1_at

Tumor Necrosis Factor Receptor Superfamily, Member 21

3.32

-1.4

Gga.5743.1.S1_at

LY96, MD-2

3.31

-3.02

GgaAffx.20689.1.S1_at

Spleen Focus Forming Virus (SFFV) Proviral Integration Oncogene (SPI-1, PU.1)

3.29

-2.58

Gga.815.1.S1_at

CD51, Integrin Alpha V

3.02

-2.36

GgaAffx.20858.1.S1_at

Cell Adhesion Molecule with Homology to L1CAM Precursor (CHL1)

2.89

-2.24

Gga.2039.1.S1_at

Heme Oxygenase (decycling) 1 (HMOX1)

2.88

-2.69

GgaAffx.11713.1.S1_s_at

Rho Guanine Nucleotide Exchange Factor 3 (GEF-3)

2.74

-1.8

Gga.3070.1.S1_at

CD121A, Interleukin-1 Receptor Type I

2.65

-3.35

Gga.1980.1.S1_s_at

Thrombospondin 4 (THBS4)

2.59

-2.6

Gga.11824.1.S1_at

Cystatin F, Leukocystatin

2.53

-3.57

Gga.4507.1.S1_at

CD18, Integrin Beta 2

2.27

-2.61

GgaAffx.24377.2.S1_s_at

Beta Parvin

2.22

-2.93

Gga.7769.1.S1_at

Fgd5, FYVE, RhoGEF and PH Domain Containing 5

2.15

-2.87

Gga.7528.1.S1_at

Kruppel-like Factor 2 (KLF-2)

2.07

-1.91

GgaAffx.1733.2.S1_s_at

CD62P, Cell Adhesion Molecule LECAM3

1.37

-3.73

Table 2

Genes significantly upregulated in nRBCs shown by gene categorization according to functional association. From left to right, genes with a known role in HSCs, myeloid cell lineage, lymphoid cell lineage, other types of non-hematopoietic cells (germ cells, neuronal or cardiac progenitors) or genes with no known role in development. Genes highlighted in bold were verified by PCR.

HSC (22)

Myeloid (17)

Lymphoid (10)

Germ Line (2)

BLNK

CD36

β-Defensin

Fragilis

CD18

CD49B

CD121A

Zov3

CD45

Cd51

HMOX1

 

CD49B

CD61

LECT2

Neural (2)

CD49F

CD62P

MD1

PTN

CD51

CD200R

MD2

TSP4

CD61

Coagulation Factor X

TLR7

 

CD62L

Coagulation Factor XIII

TNFSF13b

Cardiac (2)

CD166

COX-1

TNFSFR21

Elfin

CD200R

Gelsolin

SLAP

PINCH1

Cx43

PAI-1

  

Cystatin F

PDGFA

 

Unknown (8)

ETS-1

PLCG2

 

β-PARVIN

FYN

PU.1

 

FGD3

KLF2

Thrombin Receptor

 

FGD5

LYN

Tissue Factor Pathway Inhibitor

 

IL1RAP

PU.1

VAV3

 

L1CAM

Rac2

  

MSRA

RGS18

  

TNFAIP8

Slo1

  

TSPAN6

SYK

   

VAV3

   

Myeloid Markers Expressed by nRBCs

In addition to the expression of GPs on HSCs, expression of the platelet GP ligand CD62P (P-selectin), important for HSC adherence [20], and the myeloid GPs CD200R [21] and CD36 [22] were detected in the nRBC population. Other markers of the undifferentiated myeloid lineage including gelsolin [23] and PU.1 were both detected in nRBC fraction. Furthermore, many genes detected in nRBCs can be associated with platelet activation pathways such as, Coagulation Factors X and XIII, COX-1, PAI, PDGF, PLCG2, Tissue Factor Pathway Inhibitor, Thrombin Receptor, and VAV3 [2427].

Lymphoid Markers Expressed by nRBCs

Our expression profiling of nRBCs reveals not only the known potential of early circulating embryonic cells towards myeloid and erythroid lineages, but also that of the lymphoid lineage. The expression of leukocyte specific genes which are part of the innate immune system such as the lymphocyte antigens LY64 (MD1) and LY96 (MD2), Toll-like receptor 7 (TLR7) [28] as well as Interleukin 1 Receptor (CD121A) [29], β-Defensin [28], members of the TNF signaling pathway, TNFSF13b (BAFF) and TNFSFR21 (DR6), which can mediate the innate immune response [30], and LECT2, which is involved in neutrophil chemotaxis [31], demonstrate that a lymphoid differentiation potential is already present at the peri-aortic stage, a finding which has been reported previously for similarly staged AGM derived cells in mice [32]. The only gene expressed in nRBCs which has a role in acquired immunity appears to be the Src-like adaptor molecule, SLAP, whose function is to repress surface IgM expression on B-cells [33]. Interestingly, the heme oxygenase-1 (HMOX1) an essential enzyme in heme catabolism, was the only true erythroid associated gene detected in the nRBCs. However, the expression of HMOX1 has been reported in a variety of primitive and definitive white blood cell types as well, although it does not appear to be essential for their development [34].

Germ Cell, Neural, and Cardiac Markers Expressed by nRBCs

Additional categories of genes that were observed in nRBCs include: Fragilis and Zov3 (associated with germ cells) [35, 36], and Pleiotrophin (PTN) and Thrombospondin-4 (THSB4) (found in neuronal stem cells and progenitors) [37, 38]. Moreover, despite being negatively screened against genes upregulated in the heart (Fig. 3), Elfin, and PINCH-1, which mark early cardiac cells [39, 40], were detected in circulating nRBCs.

Additional Genes Expressed by nRBCs

Finally, a list of genes with unknown functions has emerged from this screen. Although the Interleukin-1 Receptor Associated Protein (IL1RAP) and TNF-alpha Interacting Protein 8 (TNFAIP8) are likely to be involved in the innate immune response, the other 6 genes remain developmentally uncharacterized, and may provide insight into the function and differentiation of HSCs (Table 2). Interestingly, the Peptide Methionine Sulfoxide Reductase gene (MSRA), which was expressed in nRBCs, may help to protect progenitor cells against oxidative stress [41], although conclusive proof to this end remains to be demonstrated.

Further Expression Validation: ISH, IHC and FACS

Following our expression profiling at the in vitro level, we next verified our expression data for certain interesting candidate nRBC expressed genes, for which QPCR had been performed, by wholemount is situ hybridization (ISH) and immunostaining (IHC) of the yolk sac. At E4 and E6, the time points analyzed, the yolk sac is highly vascularized and provides a receptacle for circulating cells transiting to and from the embryonic and extraembryonic regions. Reproducible labeling of rare positive circulating cells was observed for CD61, CD200R, and HEX, whereas infrequent clusters of positive cells were found to express RGS18 by ISH (Fig. 4). Furthermore, HEX expression was observed in large numbers of mesenchymal cells neighboring blood vessels either containing, or devoid of HEX positive circulating cells. CD200R occasionally labeled cells with an endothelial morphology. IHC for the CD51/CD61 heterodimer or vitronectin receptor (alpha3betaV integrin) revealed expression in rare circulating small rounded cells which were either clumped and associated with the endothelium, or singular. FACS analysis using this antibody demonstrated that 4% of nRBCs are positive for this antigen, whereas RBC staining was negligible (Fig. 5). ρ-globin, which is still prominently expressed in both E4 and E6 RBCs [42], was used as a positive control for yolk sac ISH (Fig. 4). ρ expression was observed in the majority of circulating cells, but was negative in certain infrequent cells presenting non-RBC morphology.
Figure 4

In situ hybridization and histological analyses. From the 12 candidate genes used for QPCR 6 probes were generated that gave some positive signal at earlier embryonic stages; 4 of these stained small numbers of cells in the yolk sac, with the remaining 2 no positive cells were detectable. Embryonic ρ-globin is expressed in the vast majority of circulating cells but is observed to be negative in some rare cells (arrows), whereas CD200R, CD61, HEX, RGS18 and the vitronectin receptor (CD51/61) are expressed in scattered circulating (arrows) and attached cells (arrowheads) throughout the yolk sac vasculature. Red contours outline the vascular lumen. Left and right panels indicate distinct staining of single cells with the indicated probe or antibody. Bars = 20 μm.

Figure 5

FACS profile of fractionated blood stained with PE-conjugated vitronectin receptor antibody 23C6. The number of positive cells is significantly increased in nRBCs.

Conclusion

In summary, gene expression profiling of nRBCs in the chick embryo has revealed the expression of a set of genes indicative of a wide range of hematopoietic stem cells and progenitors primarily of either the erythroid or myeloid lineages present in early circulation. It has indeed been postulated that cells with an "erythromyeloid" potential constitute the first subset of HSCs with potential for liver engraftment and eventual long-term hematopoiesis in the bone marrow [43]. Lastly, the identification of several previously undescribed genes may prompt closer examination of their functions in chick and other model organisms. We, however, do not observe a prominent difference in expression profiles between E4 nRBCs and E6 nRBCs, during which period the second wave of HSC generation is actively taking place in the peri-aortic region, transiting from the initial appearance of intra-aortic clusters at about E4 to the formation of para-aortic foci at E6 [4]. It is therefore unclear whether the nRBCs we detect in E4-6 circulation, with the profiles of hematopoietic cells and progenitors, represent those from yolk sac or peri-aortic cells.

Methods

Blood Isolation

Blood was collected from the embryonic ventricles using fine glass microcapillaries. Cells were washed in PBS-EDTA, centrifuged at 1500 g, and separated on a RediGrad:NaCl (9:2.5) density gradient (Amersham) by centrifugation for 20 minutes at 10,000 g. Upper nRBC and lower RBC populations were collected by pipette and placed in RNA lysis buffer or assayed using chemical stains or FACS.

Benzidine Staining

RBC and nRBC populations were smeared onto glass slides and fixed in 2.5% gluteraldehyde for 1 hr. A 0.1% Benzidine staining solution was then applied (0.001 g/ml benzidine; 0.0068 g/ml imidazole; 0.05 M Tris-HCl, pH7.6; 0.3% H2O2) for 1 hr at 37°C. Slides were then briefly washed in PBS, dehydrated in ethanol, mounted and photographed.

RNA Isolation and RT-PCR

Cells were lysed using QIAshredder spin columns and total RNA was extracted using the RNeasy total RNA extraction kit (Qiagen). Equal amounts of total RNA from each sample were converted to first-strand cDNA in parallel with the Superscript III reverse transcriptase synthesis system (Invitrogen). Real-time QPCR was performed using Quantitect SYBR PCR master mix (Qiagen) in a 7900 HT Fast Real-Time PCR System (Applied Biosystems). All PCRs were performed in duplicate with at least 2 biological samples at an annealing temperature of 60°C, using between 30 and 45 amplification cycles. Analysis of the melting curve excluded the amplification of unspecific products. In each QPCR run, a standard curve was generated using duplicate 6-log spanning serial dilutions. PCR products for standard curves were column-purified, measured for DNA concentration, sized by agarose gel electrophoresis, sequenced, aliquoted and stored at -80°C for a maximum of 2 months. Standard curves were calculated by SDS software, and test samples were fitted to the generated curve (Applied Biosystems). Primer sequences are available in Table 3.
Table 3

Primer sequences used for PCR and in situ probe generation

PCR PRIMERS

 

18S rRNA FORWARD

CGAAAGCATTTGCCAAGAAT

18S rRNA REVERSE

GAGTCGGCATCGTTTATGGT

BLNK FORWARD

GAAATCGCCTTCATCCAAAA

BLNK REVERSE

ACCAAGGAGGTATGCTGGTG

CD34 FORWARD

GCAACAACACTGCTCAGCTC

CD34 REVERSE

TTGCTGACACCACCAGATGT

CD36 FORWARD

AAGGAAAGACCCTTGCCAAT

CD36 REVERSE

ATTGCTGCAGTTTCCATTCC

CD45 FORWARD

GCCAAGAGGAGCCATAATCA

CD45 REVERSE

ATCCTGGGTCTCCTGGAATC

CD49B FORWARD

AAAAGAAACGTTGCAAATGAAAT

CD49B REVERSE

GTTTCTGACTTCTCTGCTGCAA

CD51 FORWARD

CATTGAAGGAGACGTGCAAA

CD51 REVERSE

AGTTTGGGTCCAAAGTCGTG

CD61 FORWARD

TTAACAACCCCTTGGCTGTC

CD61 REVERSE

CCACCGAGGTAAGGATGAGA

CD200R FORWARD

TGGTGACTGTCCTTGTGGAA

CD200R REVERSE

GACACAGTGGAGGTGGAACC

Elfin FORWARD

AGCTGCAATAGCCAACCTGT

Elfin REVERSE

GCTCATCTGCACAGCTCTTG

GAPDH FORWARD

TGGGTGTCAACCATGAGAAA

GAPDH REVERSE

CATCCACCGTCTTCTGTGTG

HEX FORWARD

CCCAGATTTCCCATTTCAGA

HEX REVERSE

TACACGAGCAGAGAGGGACA

Pan globin FORWARD

ACCGCCAAGTACCGTTAAGA

Pan globin REVERSE

TTCATCTCATTTGGCTGCTC

RGS18 FORWARD

AAATAAGTGGCAAGCAAAGTTGA

RGS18 REVERSE

CAGCAATAAGTTGCCTGGTTG

Vav3 FORWARD

TCCGCTTGCAAACAATTACA

Vav3 REVERSE

CTCAGGGTGATGGGGAGATA

ISH PROBE PRIMERS

 

CD61 FORWARD

CACCGTGTGTGATGAGAAAA

CD61 REVERSE

ACAGGTTTGATGGTGAAGGA

CD200 FORWARD

TGGCTCTGTACTGCGATGAC

CD200 REVERSE

GAACAGCAAGGGAAAACCAA

CD200 T7 REVERSE

TAATACGACTCACTATAGGGAACAGC

HEX FORWARD

GACTACACGCACGCACTGATC

HEX REVERSE

CAAACTGCTATGTACACGAGCAG

RGS18 FORWARD

CTTCCCACTACCTGCTCTGC

RGS18 REVERSE

GGACCGTGATCGTCTCCTAA

RGS18 T7 REVERSE

TAATACGACTCACTATAGGGGACCGTG

Affymetrix Array Data Analysis

Amplification of 100 ng of RNA using the Two-Cycle cDNA Synthesis Kit and IVT Labeling Kit (Affymetrix) and subsequent hybridization and scanning was carried out by the Functional Genomics Unit (RIKEN CDB). Pivot raw data files from duplicate microarray experiments were analyzed using the TIGR MultiExperiment Viewer 4.0 (TM4) software package. Briefly, data was log2 transformed, subjected to quantile normalization and analyzed by SAM (Significance Analysis for Microarrays), using 100 random data permutations, and a delta value of 2.5 (p value 0.0018) (Fig. 6). This cutoff was used to minimize false positives, but as a consequence created potential false negatives. A number of previously described hematopoietic markers such as RUNX-1 (Affy ID: Gga.1019.1.S1_at) and cKIT (Affy ID: Gga.606.1.S1_at) were found using a delta value of 0.9 (p value 0.05), but were excluded from our analysis. Hierarchical clustering of significant data points was then carried out by Co-variance algorithm [44]. All significant data points generated by SAM analysis were double checked manually using the eXintegrator software package [45, 46] against negative control E6 embryonic heart array data, which was not performed in duplicate. Data points with high expression in heart were eliminated (Fig. 3). Quality control of microarray data, which was well within an acceptable range, was performed using the Bioconductor Affy array analysis suite [47].
Figure 6

Statistical analyses of the complexity of RBC and nRBC transcriptomes. (A) Summary of present (P) calls for all arrays used in this study as a percentage of all calls (either present, P; absent, A; or missing, M). nRBCs have 10% more P calls than RBCs. Nevertheless, 1/4 of the RBC transcriptome is scored as present. (B) Graphical representation of SAM analysis showing significantly different genes between nRBCs and RBCs in red, which were examined in this study. (C) Grouped T-test between RBCs and nRBCs shows that for a confidence level of 95%, 98% of the hybridization values for probe sets between these two groups are not significantly different.

Wholemount ISH and IHC

Yolk sacs from E4 and E6 embryos were collected and fixed in 4% paraformaldehyde, and cut into small pieces to allow greater probe and antibody diffusion. For ISH, samples were processed as described previously [48]. Probes for CD200R and RGS18 were generated by 2 round PCR using primers given in Table 3. Probes for CD61, ρ-globin and HEX were cloned into pGEM-T vector. The probe for embryonic ρ-globin has been described previously [42]. Probe templates were verified by sequencing. RNA probes were generated by either T7 or Sp6 in vitro transcription, and verified by agarose gel electrophoresis. For IHC, all solutions were TBST based. Tissue was blocked for 1 hr (5% sheep serum 1 mg/ml BSA), incubated with mouse anti-human vitronectin antibody, clone 23C6, with known cross reactivity in chicken [49] (BioLegend) at a dilution of 1:40 overnight at 4°C, washed once and blocked for endogenous peroxidase activity, washed again 3×, incubated for 1 hr in secondary HRP conjugated anti-mouse, washed 3×, and developed using DAB solution (Sigma-Aldrich). All tissues were embedded in wax and sectioned to 9 μm on a MICROM HM325 Microtome. IHC samples were counterstained with hematoxylin.

FACS

Fluorescent Assisted Cell Sorting (FACS) analysis was performed on a BD FACSAria. RBC and nRBCs were separated as described and blocked for 30 min in DMEM/3% FCS (Invitrogen), incubated for 1 hr in either 1:40 PE-conjugated mouse anti-human vitronectin (see IHC) or BD PE-conjugated mouse secondary antibody (negative control, not shown), washed twice in blocking buffer and analyzed. Positive cell counts were observed and recorded using BD FACSDiva software.

Declarations

Acknowledgements

We would like to thank Dr. Yuping Wu for embryology assistance, Junko Nishio for performing microarray hybridizations, and Dr. Masahiro Shin for providing the HEX probe. We would also like to thank Dr. Gen Niimi for providing reagents for benzidine staining. We thank Dr. Kazuki Kurimoto, Laboratory for Mammalian Germ Cell Biology, RIKEN CDB, for his useful discussions regarding microarray data analysis. QC array analyses were performed by Dr. Vassil Vassilev, Laboratory for Sensory Development, RIKEN CDB. B.A.S.Mc. has been supported by a Visiting Postdoctoral Research Fellowship from the Japanese Society for the Promotion of Science (JSPS).

Authors’ Affiliations

(1)
Laboratory for Early Embryogenesis, RIKEN Center for Developmental Biology
(2)
Stem Cell Translational Research, Institute for Biomedical Research and Innovation
(3)
Genome Resource and Analysis Unit, RIKEN Center for Developmental Biology
(4)
Laboratory for Stem Cell Biology, RIKEN Center for Developmental Biology

References

  1. Mikkola HK, Orkin SH: The journey of developing hematopoietic stem cells. Development. 2006, 133 (19): 3733-3744. 10.1242/dev.02568.View ArticlePubMedGoogle Scholar
  2. Jaatinen T, Hemmoranta H, Hautaniemi S, Niemi J, Nicorici D, Laine J, Yli-Harja O, Partanen J: Global gene expression profile of human cord blood-derived CD133+ cells. Stem Cells. 2006, 24 (3): 631-641. 10.1634/stemcells.2005-0185.View ArticlePubMedGoogle Scholar
  3. Cumano A, Godin I: Pluripotent hematopoietic stem cell development during embryogenesis. Curr Opin Immunol. 2001, 13 (2): 166-171. 10.1016/S0952-7915(00)00200-4.View ArticlePubMedGoogle Scholar
  4. Dieterlen-Lievre F, Le Douarin NM: From the hemangioblast to self-tolerance: a series of innovations gained from studies on the avian embryo. Mech Dev. 2004, 121 (9): 1117-1128. 10.1016/j.mod.2004.06.008.View ArticlePubMedGoogle Scholar
  5. Marshall CJ, Thrasher AJ: The embryonic origins of human haematopoiesis. Br J Haematol. 2001, 112 (4): 838-850. 10.1046/j.1365-2141.2001.02537.x.View ArticlePubMedGoogle Scholar
  6. Pardanaud L, Dieterlen-Lievre F: Expression of C-ETS1 in early chick embryo mesoderm: relationship to the hemangioblastic lineage. Cell Adhes Commun. 1993, 1 (2): 151-160. 10.3109/15419069309095691.View ArticlePubMedGoogle Scholar
  7. Crompton MR, Bartlett TJ, MacGregor AD, Manfioletti G, Buratti E, Giancotti V, Goodwin GH: Identification of a novel vertebrate homeobox gene expressed in haematopoietic cells. Nucleic Acids Res. 1992, 20 (21): 5661-5667. 10.1093/nar/20.21.5661.View ArticlePubMed CentralPubMedGoogle Scholar
  8. Basu P, Morris PE, Haar JL, Wani MA, Lingrel JB, Gaensler KM, Lloyd JA: KLF2 is essential for primitive erythropoiesis and regulates the human and murine embryonic beta-like globin genes in vivo. Blood. 2005, 106 (7): 2566-2571. 10.1182/blood-2005-02-0674.View ArticlePubMed CentralPubMedGoogle Scholar
  9. Shivdasani RA, Orkin SH: The transcriptional control of hematopoiesis. Blood. 1996, 87 (10): 4025-4039.PubMedGoogle Scholar
  10. Cooke MP, Perlmutter RM: Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. New Biol. 1989, 1 (1): 66-74.PubMedGoogle Scholar
  11. Park IK, Klug CA, Li K, Jerabek L, Li L, Nanamori M, Neubig RR, Hood L, Weissman IL, Clarke MF: Molecular cloning and characterization of a novel regulator of G-protein signaling from mouse hematopoietic stem cells. J Biol Chem. 2001, 276 (2): 915-923. 10.1074/jbc.M005947200.View ArticlePubMedGoogle Scholar
  12. Weston VJ, Stankovic T: Rac1 and Rac2 GTPases in haematopoiesis. Bioessays. 2004, 26 (3): 221-224. 10.1002/bies.20017.View ArticlePubMedGoogle Scholar
  13. Tada J, Omine M, Suda T, Yamaguchi N: A common signaling pathway via Syk and Lyn tyrosine kinases generated from capping of the sialomucins CD34 and CD43 in immature hematopoietic cells. Blood. 1999, 93 (11): 3723-3735.PubMedGoogle Scholar
  14. Diaz-Blanco E, Bruns I, Neumann F, Fischer JC, Graef T, Rosskopf M, Brors B, Pechtel S, Bork S, Koch A, Baer A, Rohr UP, Kobbe G, Haeseler A, Gattermann N, Haas R, Kronenwett R: Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia. 2007, 21 (3): 494-504. 10.1038/sj.leu.2404549.View ArticlePubMedGoogle Scholar
  15. Li GR, Deng XL, Sun H, Chung SS, Tse HF, Lau CP: Ion channels in mesenchymal stem cells from rat bone marrow. Stem Cells. 2006, 24 (6): 1519-1528. 10.1634/stemcells.2005-0307.View ArticlePubMedGoogle Scholar
  16. Boquest AC, Shahdadfar A, Fronsdal K, Sigurjonsson O, Tunheim SH, Collas P, Brinchmann JE: Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell. 2005, 16 (3): 1131-1141. 10.1091/mbc.E04-10-0949.View ArticlePubMed CentralPubMedGoogle Scholar
  17. Spertini O, Cordey AS, Monai N, Giuffre L, Schapira M: P-selectin glycoprotein ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34+ hematopoietic progenitor cells. J Cell Biol. 1996, 135 (2): 523-531. 10.1083/jcb.135.2.523.View ArticlePubMedGoogle Scholar
  18. Halfon S, Ford J, Foster J, Dowling L, Lucian L, Sterling M, Xu Y, Weiss M, Ikeda M, Liggett D, Helms A, Caux C, Lebecque S, Hannum C, Menon S, McClanahan T, Gorman D, Zurawski G: Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells. J Biol Chem. 1998, 273 (26): 16400-16408. 10.1074/jbc.273.26.16400.View ArticlePubMedGoogle Scholar
  19. Cancelas JA, Koevoet WL, de Koning AE, Mayen AE, Rombouts EJ, Ploemacher RE: Connexin-43 gap junctions are involved in multiconnexin-expressing stromal support of hemopoietic progenitors and stem cells. Blood. 2000, 96 (2): 498-505.PubMedGoogle Scholar
  20. Zannettino AC, Berndt MC, Butcher C, Butcher EC, Vadas MA, Simmons PJ: Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood. 1995, 85 (12): 3466-3477.PubMedGoogle Scholar
  21. Jenmalm MC, Cherwinski H, Bowman EP, Phillips JH, Sedgwick JD: Regulation of myeloid cell function through the CD200 receptor. J Immunol. 2006, 176 (1): 191-199.View ArticlePubMedGoogle Scholar
  22. Tandon NN, Lipsky RH, Burgess WH, Jamieson GA: Isolation and characterization of platelet glycoprotein IV (CD36). J Biol Chem. 1989, 264 (13): 7570-7575.PubMedGoogle Scholar
  23. Lee S, Zhou G, Clark T, Chen J, Rowley JD, Wang SM: The pattern of gene expression in human CD15+ myeloid progenitor cells. Proc Natl Acad Sci U S A. 2001, 98 (6): 3340-3345. 10.1073/pnas.051013798.View ArticlePubMed CentralPubMedGoogle Scholar
  24. McNicol A, Israels SJ: Platelets and anti-platelet therapy. J Pharmacol Sci. 2003, 93 (4): 381-396. 10.1254/jphs.93.381.View ArticlePubMedGoogle Scholar
  25. Monroe DM, Hoffman M: What does it take to make the perfect clot?. Arterioscler Thromb Vasc Biol. 2006, 26 (1): 41-48. 10.1161/01.ATV.0000193624.28251.83.View ArticlePubMedGoogle Scholar
  26. Reuter HD: Basic Elements and Practice of Platelet Function Diagnostics. Science Data Supply, Köln, Germany. 1999Google Scholar
  27. Pearce AC, Senis YA, Billadeau DD, Turner M, Watson SP, Vigorito E: Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen. J Biol Chem. 2004, 279 (52): 53955-53962. 10.1074/jbc.M410355200.View ArticlePubMedGoogle Scholar
  28. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol. 2003, 21: 335-376. 10.1146/annurev.immunol.21.120601.141126.View ArticlePubMedGoogle Scholar
  29. Randow F, Seed B: Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat Cell Biol. 2001, 3 (10): 891-896. 10.1038/ncb1001-891.View ArticlePubMedGoogle Scholar
  30. Watts TH: TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol. 2005, 23: 23-68. 10.1146/annurev.immunol.23.021704.115839.View ArticlePubMedGoogle Scholar
  31. Yamagoe S, Yamakawa Y, Matsuo Y, Minowada J, Mizuno S, Suzuki K: Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. Immunol Lett. 1996, 52 (1): 9-13. 10.1016/0165-2478(96)02572-2.View ArticlePubMedGoogle Scholar
  32. Minasi MG, Riminucci M, De Angelis L, Borello U, Berarducci B, Innocenzi A, Caprioli A, Sirabella D, Baiocchi M, De Maria R, Boratto R, Jaffredo T, Broccoli V, Bianco P, Cossu G: The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development. 2002, 129 (11): 2773-2783.PubMedGoogle Scholar
  33. Dragone LL, Myers MD, White C, Sosinowski T, Weiss A: SRC-like adaptor protein regulates B cell development and function. J Immunol. 2006, 176 (1): 335-345.View ArticlePubMedGoogle Scholar
  34. Zelenay S, Chora A, Soares MP, Demengeot J: Heme oxygenase-1 is not required for mouse regulatory T cell development and function. Int Immunol. 2007, 19 (1): 11-18. 10.1093/intimm/dxl116.View ArticlePubMedGoogle Scholar
  35. Tanaka SS, Nagamatsu G, Tokitake Y, Kasa M, Tam PP, Matsui Y: Regulation of expression of mouse interferon-induced transmembrane protein like gene-3, Ifitm3 (mil-1, fragilis), in germ cells. Dev Dyn. 2004, 230 (4): 651-659. 10.1002/dvdy.20085.View ArticlePubMedGoogle Scholar
  36. Kunita R, Nakabayashi O, Kikuchi T, Mizuno S: Predominant expression of a Z-chromosome-linked immunoglobulin superfamily gene, ZOV3, in steroidogenic cells of ovarian follicles and in embryonic gonads of chickens. Differentiation. 1997, 62 (2): 63-70. 10.1046/j.1432-0436.1997.6220063.x.View ArticlePubMedGoogle Scholar
  37. Jung CG, Hida H, Nakahira K, Ikenaka K, Kim HJ, Nishino H: Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derived nestin-positive cells. Faseb J. 2004, 18 (11): 1237-1239.PubMedGoogle Scholar
  38. Arber S, Caroni P: Thrombospondin-4, an extracellular matrix protein expressed in the developing and adult nervous system promotes neurite outgrowth. J Cell Biol. 1995, 131 (4): 1083-1094. 10.1083/jcb.131.4.1083.View ArticlePubMedGoogle Scholar
  39. Kotaka M, Lau YM, Cheung KK, Lee SM, Li HY, Chan WY, Fung KP, Lee CY, Waye MM, Tsui SK: Elfin is expressed during early heart development. J Cell Biochem. 2001, 83 (3): 463-472. 10.1002/jcb.1244.View ArticlePubMedGoogle Scholar
  40. Martinsen BJ, Neumann AN, Frasier AJ, Baker CV, Krull CE, Lohr JL: PINCH-1 expression during early avian embryogenesis: implications for neural crest and heart development. Dev Dyn. 2006, 235 (1): 152-162. 10.1002/dvdy.20616.View ArticlePubMedGoogle Scholar
  41. Moskovitz J, Flescher E, Berlett BS, Azare J, Poston JM, Stadtman ER: Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc Natl Acad Sci U S A. 1998, 95 (24): 14071-14075. 10.1073/pnas.95.24.14071.View ArticlePubMed CentralPubMedGoogle Scholar
  42. Nakazawa F, Nagai H, Shin M, Sheng G: Negative regulation of primitive hematopoiesis by the FGF signaling pathway. Blood. 2006, 108 (10): 3335-3343. 10.1182/blood-2006-05-021386.View ArticlePubMedGoogle Scholar
  43. McGrath KE, Palis J: Hematopoiesis in the yolk sac: more than meets the eye. Exp Hematol. 2005, 33 (9): 1021-1028. 10.1016/j.exphem.2005.06.012.View ArticlePubMedGoogle Scholar
  44. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J: TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003, 34 (2): 374-378.PubMedGoogle Scholar
  45. Jakt LM: Website title. [http://www.cdb.riken.go.jp/scb/documentation/index.html]
  46. Takebe A, Era T, Okada M, Martin Jakt L, Kuroda Y, Nishikawa S: Microarray analysis of PDGFR alpha+ populations in ES cell differentiation culture identifies genes involved in differentiation of mesoderm and mesenchyme including ARID3b that is essential for development of embryonic mesenchymal cells. Dev Biol. 2006, 293 (1): 25-37. 10.1016/j.ydbio.2005.12.016.View ArticlePubMedGoogle Scholar
  47. Heber S, Sick B: Quality assessment of Affymetrix GeneChip data. Omics. 2006, 10 (3): 358-368. 10.1089/omi.2006.10.358.View ArticlePubMedGoogle Scholar
  48. Stern CD: Detection of multiple gene products simultaneously by in situ hybridization and immunohistochemistry in whole mounts of avian embryos. Curr Top Dev Biol. 1998, 36: 223-243.View ArticlePubMedGoogle Scholar
  49. Solari F, Flamant F, Cherel Y, Wyers M, Jurdic P: The osteoclast generation: an in vitro and in vivo study with a genetically labelled avian monocytic cell line. J Cell Sci. 1996, 109 ( Pt 6): 1203-1213.Google Scholar

Copyright

© McIntyre et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.